|
1
|
Verbeke C, Löhr M, Karlsson JS and Del
Chiaro M: Pathology reporting of pancreatic cancer following
neoadjuvant therapy: challenges and uncertainties. Cancer Treat
Rev. 41:17–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hidalgo M, Cascinu S, Kleeff J, Labianca
R, Löhr JM, Neoptolemos J, Real FX, Van Laethem JL and Heinemann V:
Addressing the challenges of pancreatic cancer: Future directions
for improving outcomes. Pancreatology. 15:8–1829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bardeesy N and DePinho RA: Pancreatic
cancer biology and genetics. Nat Rev Cancer. 3:897–909. 2002.
View Article : Google Scholar
|
|
5
|
Partensky C: Toward a better understanding
of pancreatic ductal adenocarcinoma: glimmers of hope? Pancreas.
42:729–739. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Herreros-Villanueva M, Zhang JS, Koenig A,
Abel EV, Smyrk TC, Bamlet WR, de Narvajas AA, Gomez TS, Simeone DM,
Bujanda L and Billadeau DD: SOX2 promotes dedifferentiation and
imparts stem cell-like features to pancreatic cancer cells.
Oncogenesis. 2:e612013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han JB, Sang F, Chang JJ, Hua YQ, Shi WD,
Tang LH and Liu LM: Arsenic trioxide inhibits viability of
pancreatic cancer stem cells in culture and in a xenograft model
via binding to SHHGli. Onco Targets Ther. 6:1129–1138. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Liu Q, Hou B, Zhang W, Yan M, Jia
H, Li H, Yan D, Zheng F, Ding W, et al: Concomitant targeting of
multiple key transcription factors effectively disrupts cancer stem
cells enriched in side population of human pancreatic cancer cells.
PLoS One. 8:e739422013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lu Y, Zhu H, Shan H, Lu J, Chang X, Li X,
Lu J, Fan X, Zhu S, Wang Y, et al: Knockdown of Oct4 and Nanog
expression inhibits the stemness of pancreatic cancer cells. Cancer
Lett. 340:113–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu T, Chang YF, Xiao Z, Mao R, Tong J,
Chen B, Liu GC, Hong Y, Chen HL, Kong SY, et al: miR-1 inhibits
progression of high-risk papillomavirus-associated human cervical
cancer by targeting G6PD. Oncotarget. 7:86103–86116.
2016.PubMed/NCBI
|
|
11
|
Hiyoshi Y, Kamohara H, Karashima R, Sato
N, Imamura Y, Nagai Y, Yoshida N, Toyama E, Hayashi N, Watanabe M,
et al: MicroRNA-21 regulates the proliferation and invasion in
esophageal squamous cell carcinoma. Clin Cancer Res. 15:1915–1922.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moriyama T, Ohuchida K, Mizumoto K, Yu J,
Sato N, Nabae T, Takahata S, Toma H, Nagai E and Tanaka M:
MicroRNA-21 modulates biological functions of pancreatic cancer
cells including their proliferation, invasion and chemoresistance.
Mol Cancer Ther. 8:1067–1074. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park EY, Chang E, Lee EJ, Lee HW, Kang HG,
Chun KH, Woo YM, Kong HK, Ko JY, Suzuki H, et al: Targeting of
miR34a-NOTCH1 axis reduced breast cancer stemness and
chemoresistance. Cancer Res. 74:7573–7582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Volinia S, Nuovo G, Drusco A, Costinean S,
Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K,
et al: Pluripotent stem cell miRNAs and metastasis in invasive
breast cancer. J Natl Cancer Inst. 106:1–8. 2014. View Article : Google Scholar
|
|
15
|
Le Large TY, Meijer LL, Prado Mato M,
Kazemier G, Frampton AE and Giovannetti E: Circulating microRNAs as
diagnostic biomarkers for pancreatic cancer. Expert Rev Mol Diagn.
15:1–5. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hou FQ, Lei XF, Yao JL, Wang YJ and Zhang
W: Tetraspanin 1 is involved in survival, proliferation and
carcinogenesis of pancreatic cancer. Oncol Rep. 34:3068–3076. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gustafsson OJ, Briggs MT, Condina MR,
Winderbaum LJ, Pelzing M, McColl SR, Everest-Dass AV, Packer NH and
Hoffmann P: MALDI imaging mass spectrometry of N-linked glycans on
formalin-fixed paraffin-embedded murine kidney. Anal Bioanal Chem.
407:2127–2139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brunner TB, Merkel S, Grabenbauer GG,
Meyer T, Baum U, Papadopoulos T, Sauer R and Hohenberger W:
Definition of elective lymphatic target volume in ductal carcinoma
of the pancreatic head based on histopathologic analysis. Int J
Radiat Oncol Biol Phys. 62:1021–1029. 2015. View Article : Google Scholar
|
|
19
|
Green MR and Sambrook J: Molecular
Cloning: A Laboratory Manual. 4th. Cold Spring Harbor Laboratory
Press; pp. 139–151. 2013
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ouchi Y, Banno Y, Shimizu Y, Ando S,
Hasegawa H, Adachi K and Iwamoto T: Reduced adult hippocampal
neurogenesis and working memory deficits in the
Dgcr8-deficientmouse model of 22q11.2 deletion-associated
schizophrenia can be rescued by IGF2. J Neurosci. 33:9408–9019.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Minemura H, Takagi K, Miki Y, Shibahara Y,
Nakagawa S, Ebata A, Watanabe M, Ishida T, Sasano H and Suzuki T:
Abnormal expression of miR-1 in breast carcinoma as a potent
prognostic factor. Cancer Sci. 106:1642–1650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mansour A, Chatila R, Bejjani N, Dagher C
and Faour WH: A novel xylene-free deparaffinization method for the
extraction of proteins from human derived formalin-fixed paraffin
embedded (FFPE) archival tissue blocks. MethodsX. 1:90–95. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen XP and Wang JP: Surgery. 8th.
People's Medical Press; pp. 302–312. 2013, PubMed/NCBI
|
|
25
|
Rosenfeld N, Aharonov R, Meiri E,
Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S,
Levy A, et al: MicroRNAs accurately identify cancer tissue origin.
Nat Biotechnol. 26:462–469. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Habbe N, Koorstra JB, Mendell JT,
Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME, Goggins MG, Hong
SM and Maitra A: MicroRNA miR-155 is a biomarker of early
pancreatic neoplasia. Cancer Biol Ther. 8:340–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bloomston M, Frankel WL, Petrocca F,
Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C and Croce
CM: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu K and Wang W: Green tea polyphenol
EGCG suppresses osteosarcoma cell growth through upregulating
miR-1. Tumour Biol. 37:4373–4382. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu X, Wu X, Jiang Q, Sun Y, Liu H, Chen R
and Wu S: Downregulation of microRNA-1 and microRNA-145 contributes
synergistically to the development of colon cancer. Int J Mol Med.
36:1630–1638. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pathak S, Meng WJ, Nandy SK, Ping J,
Bisgin A, Helmfors L, Waldmann P and Sun XF: Radiation and SN38
treatments modulate the expression of microRNAs, cytokines and
chemokines in colon cancer cells in a p53-directed manner.
Oncotarget. 6:44758–44780. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Du YY, Zhao LM, Chen L, Sang MX, Li J, Ma
M and Liu JF: The tumor-suppressive function of miR-1 by targeting
LASP1 and TAGLN2 in esophageal squamous cell carcinoma. J
Gastroenterol Hepatol. 31:384–393. 2015. View Article : Google Scholar
|
|
32
|
Liu T, Hu K, Zhao Z, Chen G, Ou X, Zhang
H, Zhang X, Wei X, Wang D, Cui M, et al: MicroRNA-1 down-regulates
proliferation and migration of breast cancer stem cells by
inhibiting the Wnt/β-catenin pathway. Oncotarget. 6:41638–41649.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu R, Li J, Lai Y, Liao Y, Liu R and Qiu
W: Hsa-miR-1 suppresses breast cancer development by
down-regulating K-ras and long non-coding RNA MALAT1. Int J Biol
Macromol. 81:491–497. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiao H, Zeng J, Li H, Chen K, Yu G, Hu J,
Tang K, Zhou H, Huang Q, Li A, et al: MiR-1 downregulation
correlates with poor survival in clear cell renal cell carcinoma
where it interferes with cell cycle regulation and metastasis.
Oncotarget. 6:13201–13215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li L, Li B, Chen D, Liu L, Huang C, Lu Z,
Lun L and Wan X: miR-139 and miR-200c regulate pancreatic cancer
endothelial cell migration and angiogenesis. Oncol Rep. 34:51–58.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lynn FC, Skewes-Cox P, Kosaka Y, McManus
MT, Harfe BD and German MS: MicroRNA expression is required for
pancreatic islet cell genesis in the mouse. Diabetes. 56:2938–2945.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
38
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang Z, Chen S, Luan X, Li Y, Liu M, Li X,
Liu T and Tang H: MicroRNA-214 is aberrantly expressed in cervical
cancers and inhibits the growth of HeLa cells. IUBMB Life.
61:1075–1082. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jindra PT, Bagley J, Godwin JG and
Iacomini J: Costimulation-dependent expression of microRNA-214
increases the ability of T cells to proliferate by targeting Pten.
J Immunol. 185:990–997. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang XJ, Ye H, Zeng CW, He B, Zhang H and
Chen YQ: Dysregulation of miR-15a and miR-214 in human pancreatic
cancer. J Hematol Oncol. 3:462010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang TS, Yang XH, Wang XD, Wang YL, Zhou B
and Song ZS: MiR-214 regulate gastric cancer cell proliferation,
migration and invasion by targeting PTEN. Cancer Cell Int.
13:682013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Flynt AS, Li N, Thatcher EJ,
Solnica-Krezel L and Patton JG: Zebrafish miR-214 modulates
Hedgehog signaling to specify muscle cell fate. Nat Genet.
39:259–263. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sasayama T, Nishihara M, Kondoh T, Hosoda
K and Kohmura E: MicroRNA-10b is overexpressed in malignant glioma
and associated with tumor invasive factors, uPAR and RhoC. Int J
Cancer. 125:1407–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nakata K, Ohuchida K, Mizumoto K,
Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima
S, et al: MicroRNA-10b is overexpressed in pancreatic cancer,
promotes its invasiveness and correlates with a poor prognosis.
Surgery. 150:916–922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Roth C, Kasimir-Bauer S, Pantel K and
Schwarzenbach H: Screening for circulating nucleic acids and
caspase activity in the peripheral blood as potential diagnostic
tools in lung cancer. Mol Oncol. 5:281–291. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nishida N, Yamashita S, Mimori K, Sudo T,
Tanaka F, Shibata K, Yamamoto H, Ishii H, Doki Y and Mori M:
MicroRNA-10b is a prognostic indicator in colorectal cancer and
confers resistance to the chemotherapeutic agent 5-fluorouracil in
colorectal cancer cells. Ann Surg Oncol. 19:3065–3071. 2012.
View Article : Google Scholar : PubMed/NCBI
|
